TABLE 6.
Negative serum reproducibility for the ELISA used in this study with sera 501a, 502a, and 401a
| Run | Operator | No. of replicates/run | No. of points/run | Within run
|
Between run
|
||
|---|---|---|---|---|---|---|---|
| %CVa | %CVb | %CVa | %CVb | ||||
| 501a | 1 | 4 | 1 | 9.8 | 11.3 | ||
| 1 | 8.1 | 8.3 | |||||
| 2 | 10.6 | 17.6 | |||||
| 3 | 9.1 | 6.2 | |||||
| 502a | 1 | 4 | 1 | 8.6 | 10.0 | ||
| 1 | 9.8 | 5.3 | |||||
| 2 | 5.7 | 3.3 | |||||
| 3 | 10.8 | 12.3 | |||||
| 401a | 1 | 4 | 1 | 15.3 | 36.2 | ||
| 1 | 7.0 | 12.3 | |||||
| 2 | 25.5 | 49.4 | |||||
| 3 | 12.0 | 23.0 | |||||
a
Average of the individual point %CVs calculated by the absorbancy of each point.
b
Average of the individual point %CVs calculated by the absorbancy of each inhibited point.